Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial
- PMID: 35343999
- PMCID: PMC8961395
- DOI: 10.1001/jamainternmed.2022.0502
Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial
Abstract
Background: Individuals with dementia or mild cognitive impairment frequently have multiple chronic conditions (defined as ≥2 chronic medical conditions) and take multiple medications, increasing their risk for adverse outcomes. Deprescribing (reducing or stopping medications for which potential harms outweigh potential benefits) may decrease their risk of adverse outcomes.
Objective: To examine the effectiveness of increasing patient and clinician awareness about the potential to deprescribe unnecessary or risky medications among patients with dementia or mild cognitive impairment.
Design, setting, and participants: This pragmatic, patient-centered, 12-month cluster randomized clinical trial was conducted from April 1, 2019, to March 31, 2020, at 18 primary care clinics in a not-for-profit integrated health care delivery system. The study included 3012 adults aged 65 years or older with dementia or mild cognitive impairment who had 1 or more additional chronic medical conditions and were taking 5 or more long-term medications.
Interventions: An educational brochure and a questionnaire on attitudes toward deprescribing were mailed to patients prior to a primary care visit, clinicians were notified about the mailing, and deprescribing tip sheets were distributed to clinicians at monthly clinic meetings.
Main outcomes and measures: The number of prescribed long-term medications and the percentage of individuals prescribed 1 or more potentially inappropriate medications (PIMs). Analysis was performed on an intention-to-treat basis.
Results: This study comprised 1433 individuals (806 women [56.2%]; mean [SD] age, 80.1 [7.2] years) in 9 intervention clinics and 1579 individuals (874 women [55.4%]; mean [SD] age, 79.9 [7.5] years) in 9 control clinics who met the eligibility criteria. At baseline, both groups were prescribed a similar mean (SD) number of long-term medications (7.0 [2.1] in the intervention group and 7.0 [2.2] in the control group), and a similar proportion of individuals in both groups were taking 1 or more PIMs (437 of 1433 individuals [30.5%] in the intervention group and 467 of 1579 individuals [29.6%] in the control group). At 6 months, the adjusted mean number of long-term medications was similar in the intervention and control groups (6.4 [95% CI, 6.3-6.5] vs 6.5 [95% CI, 6.4-6.6]; P = .14). The estimated percentages of patients in the intervention and control groups taking 1 or more PIMs were similar (17.8% [95% CI, 15.4%-20.5%] vs 20.9% [95% CI, 18.4%-23.6%]; P = .08). In preplanned subgroup analyses, adjusted differences between the intervention and control groups were -0.16 (95% CI, -0.34 to 0.01) for individuals prescribed 7 or more long-term medications at baseline (n = 1434) and -0.03 (95% CI, -0.20 to 0.13) for those prescribed 5 to 6 medications (n = 1578) (P = .28 for interaction; P = .19 for subgroup interaction for PIMs).
Conclusions and relevance: This large-scale educational deprescribing intervention for older adults with cognitive impairment taking 5 or more long-term medications and their primary care clinicians demonstrated small effect sizes and did not significantly reduce the number of long-term medications and PIMs. Such interventions should target older adults taking relatively more medications.
Trial registration: ClinicalTrials.gov Identifier: NCT03984396.
Conflict of interest statement
Figures
Similar articles
-
Anticholinergic deprescribing interventions for reducing risk of cognitive decline or dementia in older adults with and without prior cognitive impairment.Cochrane Database Syst Rev. 2023 Dec 8;12(12):CD015405. doi: 10.1002/14651858.CD015405.pub2. Cochrane Database Syst Rev. 2023. PMID: 38063254 Review.
-
Deprescribing Medications Among Older Adults From End of Hospitalization Through Postacute Care: A Shed-MEDS Randomized Clinical Trial.JAMA Intern Med. 2023 Mar 1;183(3):223-231. doi: 10.1001/jamainternmed.2022.6545. JAMA Intern Med. 2023. PMID: 36745422 Free PMC article. Clinical Trial.
-
Willingness of older people living with dementia and mild cognitive impairment and their caregivers to have medications deprescribed.Age Ageing. 2023 Jan 8;52(1):afac335. doi: 10.1093/ageing/afac335. Age Ageing. 2023. PMID: 36702513 Free PMC article.
-
The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.Trials. 2020 Jun 18;21(1):542. doi: 10.1186/s13063-020-04482-0. Trials. 2020. PMID: 32552857 Free PMC article.
-
Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Feb. Report No.: 19-05257-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Feb. Report No.: 19-05257-EF-1. PMID: 32129963 Free Books & Documents. Review.
Cited by
-
Deprescribing in Dialysis: Operationalizing "Less is More" Through a Multimodal Deprescribing Intervention.Kidney Med. 2024 Apr 4;6(5):100819. doi: 10.1016/j.xkme.2024.100819. eCollection 2024 May. Kidney Med. 2024. PMID: 38689837 Free PMC article. No abstract available.
-
Insights into designing educational materials for persons living with dementia: a focus group study.BMC Geriatr. 2024 Apr 29;24(1):380. doi: 10.1186/s12877-024-04953-y. BMC Geriatr. 2024. PMID: 38685011 Free PMC article.
-
Developing a PRogram to Educate and Sensitize Caregivers to Reduce the Inappropriate Prescription Burden in the Elderly with Alzheimer's Disease (D-PRESCRIBE-AD): Trial protocol and rationale of an open-label pragmatic, prospective randomized controlled trial.PLoS One. 2024 Feb 12;19(2):e0297562. doi: 10.1371/journal.pone.0297562. eCollection 2024. PLoS One. 2024. PMID: 38346025 Free PMC article.
-
Influence of Potentially Inappropriate Medication Use on Older Australians' Admission to Emergency Department Short Stay.Geriatrics (Basel). 2024 Jan 4;9(1):6. doi: 10.3390/geriatrics9010006. Geriatrics (Basel). 2024. PMID: 38247981 Free PMC article.
-
Introducing a pharmacist-led transmural care program to reduce drug-related problems in orthogeriatric patients: a prospective interventional study.BMC Geriatr. 2024 Jan 11;24(1):47. doi: 10.1186/s12877-023-04591-w. BMC Geriatr. 2024. PMID: 38212699 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous